Endoscopic submucosal dissection (ESD) represents a significant advance in therapeutic endoscopy with the major advantage being the ability to achieve a higher en bloc resection rate for early stage ...

A prospective clinical trial from researchers in Japan shows magnetic-anchor-guided endoscopic submucosal dissection for large early gastric cancer to be a feasible and safe method in humans.

Endoscopic submucosal dissection (ESD) of large colorectal adenomas resulted in a lower recurrence rate compared with endoscopic mucosal resection (EMR), but the more technically complex ESD had a ...

Subgroup analysis of JCOG0501 phase III study to confirm superiority of additional neoadjuvant chemotherapy with S-1 plus cisplatin to D2 gastrectomy with S-1 adjuvant chemotherapy for resectable type ...

Between May 2005 and February 2009, a total of 45 colorectal tumors in 45 patients were resected by ESD at Tochigi Cancer Center, and the data for these cases were accumulated on a prospectively ...

"New technologies in endoscopic resection are being developed toward safer techniques with improved efficacy. Techniques such as traction-assisted and tunneling are called modified ESD which would ...

Evidence-based recommendations on endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) of non-ampullary duodenal lesions. This involves using a long camera inserted through ...

The deadline for responses is midnight on 17 November 2025. Gastrointestinal lesions are growths on the lining of the gastrointestinal tract that can be cancerous or develop into cancers. Colorectal ...

Please provide your email address to receive an email when new articles are posted on . Among patients with T1 colorectal cancer, deep submucosal invasion was not a significant independent predictor ...